Multiple Myeloma Market shall be worth US$ 16.31 billion by 2030
Multiple Myeloma Market shall be worth US$ 16.31 billion by 2030, according to Renub Research. Several factors contribute to the growth of the multiple myeloma market, including an aging population, advancements in treatment options, increased awareness a